The prognostic value of ambulatory blood pressure (BP) monitoring for long-term prognosis varies in recent studies. The study aimed to investigate the role of ambulatory BP parameters in mortality and cardiovascular (CV) events in hypertensive patients. A series of 412 participants (59.3±4.0 years) who received ambulatory BP monitoring for their fluctuated BP, either untreated or treated since 1995, were enroled. The mortality and CV events were obtained by follow-up and linked to the National Death Registry in Taiwan. There were 233 untreated and 179 treated patients. The latter were older with more comorbidity when compared with the former. After follow-up for 8.5±1.7 years, both ambulatory systolic BP and pulse pressure (PP) could predict all-cause mortality, non-CV mortality, CV disease and stroke after adjusting for baseline covariates. However, only ambulatory PP could predict CV mortality and coronary heart disease. Ambulatory PP is better than ambulatory systolic BP, particularly in prediction of all-cause mortality. There was no predictive value of office BP in any outcome. In conclusion, ambulatory PP is a good predictor for long-term outcomes in hypertensive patients. The parameters of ambulatory rather than office BP could be applied for risk stratification either before or under antihypertensive treatment.
Introduction
The relation between blood pressure (BP) and the risk of cardiovascular disease (CVD) is direct, graded and continuous over a wide range. 1 Although BP measurement at the clinic is currently the standard of reference, there is considerable debate as to the most appropriate method of assessing BP in different clinical settings. Clinic BP measurements may be inappropriate for a number of reasons including inaccuracies in measurement technique and artificial increases in BP produced by 'whitecoat' effects. 2 Many studies have confirmed superiority of 24-h ambulatory BP monitoring (ABPM) over office or clinic BP measurement in predicting hypertension-induced organ damage or clinical outcome. [3] [4] [5] [6] To what extent ABPM provides an independent predictive value beyond office BP is of clinical importance, as ABPM is potentially more burdensome and associated with higher costs than office or clinic BP measurements. Previous study mainly focused on ambulatory systolic BP (SBP) 3, 4, 6, 7 or diastolic BP (DBP). 3, 4 Variation in the day-night BP pattern (the dipping status) has also been claimed as an important predictor of both target-organ damage and CV events. 4, 6, 8 However, the roles of other parameters derived from ABPM, including 24-h pulse pressure (PP), daytime PP and nighttime PP, are not fully defined. Further, previous studies were mainly conducted in Europe 3, 4, 6 and Japan. 5 Both environmental and genetic factors 9 of hypertension may be different among different ethic populations. Given the fact that hypertension is one of the major leading causes of CV events and death in Chinese, this study was conducted to systemically assess the prognostic value of these ABPM parameters on CV morbidity and mortality in an ethnic Chinese population in Taiwan.
Methods
Study population A total of 412 consecutive patients were enroled into the study. They had undergone 24-h ABPM for fluctuation of BP (SBP X140 mm Hg or DBP X90 mm Hg or both, either at home or at two or more consecutive clinical visits) either with or without antihypertensive treatment in the Taipei Veterans General Hospital between October 1995 and September 1999. Patients were defined as untreated and treated according to whether antihypertensive medication had been taken during ABPM examination. Hypertensive subjects were defined as those with SBP X140 mm Hg, DBP X90 mm Hg or prescribed at least one antihypertensive agent. Diabetes mellitus (DM) subjects were defined according to the criteria of the American Diabetes Association. 10 Hyperlipidemia subjects were defined according to the criteria of National Cholesterol Education Program Adult Treatment Panel III. 11 The study protocol was approved by the ethics committee of the Taipei Veterans General 
BP measurement
Office BP was measured by a well-trained nurse or assistant with a validated automatic digital BP monitor (Omron HEM-705CP; OMRON Healthcare, Bannockburn, IL, USA) 12 in the morning hours after sitting for 15 min in a quiet room. Three consecutive BP measurements were carried out each time at 5-min intervals. Office BPs were recorded as the average value of the last two recordings. ABPM was performed using SpaceLabs 90217 devices (SpaceLabs Inc, Wokingham, Berkshire, UK). 13 All patients were fitted with the device between 0800 and 1000 hours. The device was programmed to record BP every 15 min from 0600 to 2200 hours and every 30 min from 2200 to 0600 hours. In this analysis, daytime BP was the average BP from 0600 to 2200 hours and nighttime BP was the average BP from 2200 to 0600 hours. The PP was calculated by SBP minus DBP.
Follow-up
All of the patients were followed up in our outpatient clinics on regular basis, such as every 1-3 months. Information about clinical events was obtained from the hospital charts or telephone interview. Outcome variables were (1) all-cause mortality; (2) CV mortality, including all fatal CV events; (3) non-CV mortality; (4) CVD, including sudden death, fatal or nonfatal myocardial infarction (MI) and fatal or nonfatal stroke; (5) coronary heart disease (CHD), including sudden death and fatal or nonfatal MI; and (6) fatal or nonfatal stoke. The date and causes of mortality were also collected by linking our database with the National Death Registry through a unique, life-long personal identification number given to every Taiwan citizen. Subjects not appearing on the National Death Registry on 31 December 2007 were considered surviving. The National Death Registry database registers valid information based on the certified death certificates. The death certificates were coded according to the International Classification of Disease, Ninth Revision (ICD-9). The ICD-9 codes used for CV mortality were 390-459. The accuracy of cause-of-death coding in Taiwan's National Death Registry database has been validated. 14 
Data analysis
Statistical analysis was performed using SPSS software (version 15.0, SPSS Inc, Chicago, IL, USA). All data were expressed as frequency (percentage) or mean ± standard deviation or median with interquartile ranges. Parametric continuous data between untreated and treated groups were compared by unpaired Student's test, and nonparametric data used the Mann-Whitney test. Categorical data between untreated and treated groups were compared with w 2 -test, with Yates' correction or Fisher's exact test as appropriate. The association between each office and ambulatory BP parameters and outcome events was tested using Cox proportional hazards regression models. Each office and ambulatory BP parameter was adjusted for baseline variables: age, gender, smoking, concomitant medications (antihypertensive and lipid-lowering agents), DM, previous MI, previous stroke, congestive heart failure and hyperlipidemia. In further models, the office BP and ambulatory BP, and ambulatory SBP and PP were included into the same model for competition. Statistical significance was inferred at a two-sided P-value of o0.05.
Results

Patient characteristics at baseline in 412 participants
We enroled a total of 412 consecutive patients (mean age 59.3±14.0 years, 61.2% male) who had undergone 24-h ABPM because of unstable or unsatisfactorily controlled BP either with or without antihypertensive treatment between October 1995 and September 1999 in the Taipei Veterans General Hospital (Table 1) . There were 233 patients (56.6%) who were untreated (the untreated group), whereas another 179 (43.4%) were already under treatment (the treated group). Compared with the untreated patients, patients in the treated group were older (Po0.001) with higher office PP (P ¼ 0.017). The prevalence of DM (P ¼ 0.039) and congestive heart failure (P ¼ 0.001) were also higher in the treated group. The 24-h DBP (Po0.001), daytime DBP (Po0.001) and nighttime DBP (P ¼ 0.002) were lower, and the 24-h PP (Po0.001), daytime PP (Po0.001) and nighttime PP (Po0.001) were higher in the treated group than in the untreated group.
Prognostic values of ambulatory BP parameters in 412 participants After 8.5 ± 1.7 years of follow-up, there were 45 deaths (12 CV mortality and 33 non-CV mortality) and 42 CVD (17 CHD and 25 strokes). Table 2 showed the adjusted hazard ratios (HRs) for the outcome associated with one standard deviation increase in office and ambulatory BP parameters. All the office BP parameters failed to predict any clinical outcome.
Among the ambulatory PP parameters, 24-h PP could predict all the clinical outcomes including allcause, CV and non-CV mortality, CVD, CHD and stroke. Both daytime and nighttime PP could predict all-cause, CV and non-CV morbidity and CVD. Daytime PP could also predict CHD (Table 2) .
On the other hand, 24 h, daytime and nighttime SBP could predict all-cause mortality, CVD and stroke. Besides, although 24 h and nighttime SBP could also predict non-CV mortality, daytime SBP could further predict CHD (Table 2) . Table 3 showed the adjusted HRs for the outcome when office BP and ambulatory BP were included in the same model. It was shown that 24-h PP, rather than office PP, could predict all the CV and non-CV mortality and events. Besides, 24-h SBP, rather than office SBP, could also predict the all-cause mortality, CVD and stroke. Thus, ambulatory PP and SBP are much more prognostic than office PP and SBP. Abbreviations: ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; BMI, body mass index; BP, blood pressure; CCB, calcium channel blocker; CHF, congestive heart failure; DBP, diastolic blood pressure; DM, diabetes mellitus; MI, myocardial infarction; PP, pulse pressure; SBP, systolic blood pressure.
Ambulatory BP parameters versus office BP parameters
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Ambulatory SBP versus ambulatory PP When both ambulatory SBP and PP were included in the same model, 24-h PP and daytime PP could still predict the all-cause mortality (HR, 2.12 and 2.25, respectively). Interestingly, daytime PP, rather than daytime SBP, also predicted the non-CV mortality (HR, 1.96; 95% CI, 1.06-3.64; P ¼ 0.021) (Table 3) . Thus, compared with ambulatory SBP, ambulatory PP could be a more powerful prognostic predictor, especially in all-cause and non-CV mortality. Abbreviations: BP, blood pressure; CHD, coronary heart disease; CV, cardiovascular; CVD, cardiovascular disease; NCV, noncardiovascular; PP, pulse pressure; SBP, systolic blood pressure. Data are hazard ratios (95% confidence intervals) for each 1 s.d. higher blood pressure. Hazard ratios were also adjusted for baseline characteristics including age, gender, smoking, concomitant medications (antihypertensive and lipid-lowering drugs), diabetes mellitus, previous myocardial infarction, previous stroke, congestive heart failure and hyperlipidemia. Significance of hazard ratios: *Po0.05; w Po0.01; z Po0.001.
Discussion
The main findings of this study are that ABPM parameters have more predictive value in long-term prognosis than office BP in both treated and untreated hypertensive patients. Further, ambulatory PP parameters seem more predictive than ambulatory SBP parameters. To our knowledge, this could be the first study to show the significant prognostic impacts of ambulatory PP parameters, even superior to ambulatory SBP, on both all-cause and CV mortality in clinical hypertension. Besides, 24-h ambulatory PP may be the single most prognostic parameter, as it could predict all the long-term CV and non-CV clinical outcomes in hypertensive patients. Our findings are partially in line with the very first report that ABPM is a better predictor of morbidity than in-office BP measurement. 15 Given the potential inaccuracies in measurement technique and artificial increases in BP produced by 'white-coat' effects, 2 office or clinic BP measurement could be inferior to ABPM in predicting hypertension-induced organ damage or clinical outcome. [3] [4] [5] [6] In the current study, office BP parameters including SBP, DBP and even PP failed to predict any clinical outcome. On the other hand, ambulatory BP parameters such as 24 h, daytime and nighttime PP predicted not only CVD and mortality but also non-CV and all-cause mortality, suggesting their broad prognostic impacts in hypertensive patients.
Previous European studies have shown that ambulatory BP, over and above the conventional BP, could predict the CV risk and mortality in untreated hypertensives. 4, 16 Besides, ABPM also offers more accurate prognostic information of CV outcomes than office readings in treated hypertensive subjects. 3, 16 In this study, although treated patients were older with more comorbidity than the untreated patients, ABPM parameters could still predict the mortality and CVD in both groups. In treated hypertensives, the results remained unchanged after adjusting for concomitant antihypertensive medication.
Regarding the fact that which BP parameter is most prognostic, the answers were varied among different studies. Several epidemiological studies reported that PP is a useful predictor for CV morbidity and mortality, especially in old people. 17, 18 However, recent cohort studies including older people showed that the relationship of PP to mortality from total CVD and CHD was less strong than those of other BP indexes. 19, 20 In a metaanalysis, PP was found to be less informative in the prediction of CHD and stroke mortality than SBP or DBP.
1 Recent studies also showed the complex associations of PP with all-cause and CV mortality, depending on age, SBP and DBP, and discouraged the use of PP for diagnostic or therapeutic decisions. 21 However, the PP in these studies was mainly derived from office BP. In this study, although office PP could only predict CHD, ambulatory PP could predict all the clinical outcomes including all-cause, CV and non-CV mortality and CV events. The predictive role of 24-h ambulatory PP was even better than other BP indexes. As a result, 24-h ambulatory PP could be the single most informative predictor for long-term prognosis of hypertension.
When concerning about daytime and nighttime ambulatory BP parameters, nighttime BP seemed to be a stronger predictor of outcome than daytime BP. 4, 6 The BP parameters in these studies included SBP and DBP but not PP. In this study, both daytime and nighttime SBP could predict all-cause and non-CV mortality, but not CV mortality. More importantly, 24-h and daytime PP, rather than nighttime PP, could predict all-cause mortality even adjusted for ambulatory SBP. Given the similar prognostic impacts of 24-h and daytime PP, the measurement of daytime PP might be a convenient way for clinical risk stratification. Further large-scale studies are indicated to validate the current findings in different ethnic and geographic cohorts.
Previous ABPM studies were mainly conducted in Europe 3,4,6 and Japan. 5 There was one large-scale ABPM study composed of six population-based cohorts from three continents. 8 Recently, some international meta-analyses for ABPM predictive value were published 7, 8, 22 in addition to singlenation population studies. 4, 23 However, given the particular clinical importance of hypertension in Chinese population, our study may not only validate but also provide some novel rationales to clinical use of ABPM in ethnic Chinese hypertensives. Besides, previous studies have shown the prognostic significance of ABPM in hypertensive patients with CVD 24 or DM. 25 In this study, most of the patients were free from CVD before receiving ABPM. They had low prevalence of previous MI, previous stroke and congestive heart failure. Their prevalence of type II DM was 11.4%, which was similar to the general prevalence of DM in Taiwanese population. 26 Therefore, the current findings may reflect the real-world situation and should be validated in other specific or complicated hypertensive cohorts if indicated.
There were some limitations in this study. First, although our patients were with relatively low risk and less comorbidity, the potential effects of the comorbidity on the current results cannot be completely excluded. However, controlling these variables in the multivariate analysis did not change the results. Second, in patients with treated hypertension, the impact of different treatment regimens was modest, which was controlled in the multivariate analysis. Finally, the use of CV drugs, including antihypertensives and lipid-lowering treatment, has been adjusted during analysis in this study. However, detailed information about atrial fibrillation, the use of anticoagulants and biochemistry data were not available, although some of them might also contribute to CV events. Further 24-h pulse pressure and prognosis Y-T Kao et al study focus on the interaction between ABPM parameters and other risk profiles may be considered if indicated.
In conclusion, ABPM parameters provide more individualized risk stratification and prediction of clinical outcomes than office BP in both treated and untreated hypertensive patients. Ambulatory PP rather than other parameters predicted the future mortality and CV events, which may be applied for universal risk stratification and consequent clinical management in hypertensive patients before and even during antihypertensive treatment.
